REPORT OF THE VISUAL OUTCOMES AND PATIENT SATISFACTION OF AN ENHANCED MONOFOCAL IOL WITH MINI-MONOVISION : A PROSPECTIVE STUDY
Published 2023 - 27th ESCRS Winter Meeting
Reference: O35 | Type: Free Paper Submission | DOI: 10.82333/ehm3-tg60
Authors: Fernando Llovet* 1 , Andrea Llovet 2 , Jaime Moya 3 , Jorge Navalon 3 , Javier Coloma 4
1Cataract and Refractive Surgery,Clinica Baviera-Ayer Eye Group,Madrid,Spain;School of Medicine,Cardenal Herrera-CEU University,Valencia,Spain, 2Cataract and Refractive Surgery,Clinica Baviera-Ayer Eye Group,Valencia,Spain;Ophthalmology Department,University Hospital La Fe,Valencia,Spain, 3Cataract and Refractive Surgery,Clinica Baviera-Ayer Eye Group,Valencia,Spain, 4Cataract and Refractive Surgery,Clinica Baviera-Ayer Eye Group,A Coruña,Spain
Purpose
To evaluate the visual outcomes and patient satisfaction after implantation of an enhanced monofocal intraocular lens (IOL) for mini-monovision.
Setting
Clinica Baviera-AIER Eye Hospital Group, Spain
Methods
Prospective multicentre interventional case series included patients with bilateral primary cataract surgery and implantation of an enhanced monofocal IOL (RayOne EMV IOL RAO200E). Target refraction was -1.00 D in the non-dominant eye and emmetropia in the dominant eye. The primary outcomes were binocular uncorrected distance visual acuity (UDVA) at 4 m, binocular uncorrected intermediate visual acuity (UIVA) at 66 cm and binocular uncorrected near visual acuity (UNVA) at 40 cm at 1, 3 and 6 months postoperatively. Patient reported outcomes (PRO) were also assessed using the Spanish version of the CAT-QUEST 9SF.
Results
Studied 80 eyes of 40 patients with discharge and minimum of 3-months follow-up. After surgery, mean logMAR binocular UDVA, UIVA and UNVA were 0.08 ± 0.11, 0.22 ± 0.19 and 0.30 ± 0.10, respectively.Three months postoperatively, mean manifest refraction spherical equivalent was -0.05 ± 0.34 D and -0.92 ± 0.5 D for the dominant and non-dominant eye, respectively. Based on the CAT-QUEST 9SF at 3-months follow-up, all respondents (100%) reported spectacle independence for intermediate and distance with 29% patients not requiring glasses for near tasks. All patients also reported being satisfied with their vision, with 86% indicating that they had no difficulty driving at night. There were no adverse events reported to date.
Conclusion
Implantation of the enhanced monofocal whith mini-monovision provided excellent distance vision and a high quality of overall vision. Spectacle independence was achieved for far and intermediate distances.